EndoSure raises $1.3M in November 2026 SEC filing

- Raised in SEC filings
- $1.5M
- Filings
- 2
- Latest est. round
- Seed
- Incorporated
- 2022
- Industry
- Health care
- Based in
- MD
EndoSure, an Other Health Care company based in MD, first filed with the SEC in February 2025, reporting a $150K raise with a first sale date of February 5, 2025. This was an estimated Pre-seed/Seed round. All rounds are estimates.
The company filed again in November 2026, reporting a $1.3M raise with a first sale date of November 3, 2026. This was an estimated Seed round. The amount raised increased from the previous filing.
The latest filing names Mark Noar as an Executive Officer and Director, Mark November as a Director, and Carlos Babini as an Executive Officer and Director. We do not track EndoSure's open roles yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-11-03 | $1.3M | Seed |
| 2025-02-05 | $150K | Pre-seed/Seed |
Named in the latest filing
- Mark Noar
- Mark November
- Carlos Babini
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR